Clinical trial
A Randomized, Open-label, Two-Period, Two-Crossover Study to Compare the Safety and Pharmacokinetics of Recombinant Human Follicle Stimulating Hormone Injection (LM001) and Gonal-F® in Healthy Female Volunteers
NCT03535103 is registered in ClinicalTrials.gov with Alphamab Jilin Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open-label, Two-Period, Two-Crossover Study to Compare the Safety and Pharmacokinetics of Recombinant Human Follicle Stimulating Hormone Injection (LM001) and Gonal-F® in Healthy Female Volunteers
- Lead sponsor
- Alphamab Jilin Co., Ltd.
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- June 1, 2018
- Completion date
- December 31, 2019
- Enrollment
- 32 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.